Our University is in receipt of two agreements from NSABP (one agreement
contains language for the two drugs, and the second is the Federal
Portion).  This is a Multi-center, actually Nation Wide, study.  My
question to those of you that have received these agreements, how are you
handling these?  There are numberous problematic areas in both agreements.
Any help, information, etc., would be greatly appreciated.

Audrey
Audrey C. Buck
Senior Contract Administrator
University of Pennsylvania
Research Services
133 South 36th Street
Philadelphia, PA  19104-3246
215 537 6709 (p)
215 898 9707 (f)

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including
 subscription information and a web-searchable archive, are available
 via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================